| # | Title | Journal | Year | Citations |
|---|
| 1 | Association of Perceived Medical Errors With Resident Distress and Empathy | JAMA - Journal of the American Medical Association | 2006 | 1,169 |
| 2 | New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment | Blood | 2009 | 1,110 |
| 3 | Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma | Leukemia | 2008 | 787 |
| 4 | Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis | Mayo Clinic Proceedings | 2007 | 331 |
| 5 | Hematologic manifestations of celiac disease | Blood | 2007 | 307 |
| 6 | Essential Thrombocythemia Beyond the First Decade: Life Expectancy, Long-term Complication Rates, and Prognostic Factors | Mayo Clinic Proceedings | 2006 | 305 |
| 7 | Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma | Journal of Clinical Oncology | 2009 | 286 |
| 8 | Fracture Risk With Multiple Myeloma: A Population-Based Study | Journal of Bone and Mineral Research | 2004 | 269 |
| 9 | Career Satisfaction, Practice Patterns and Burnout among Surgical Oncologists: Report on the Quality of Life of Members of the Society of Surgical Oncology | Annals of Surgical Oncology | 2007 | 257 |
| 10 | Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data | Lancet Oncology, The | 2014 | 256 |
| 11 | Pathogenesis of Myelofibrosis With Myeloid Metaplasia | Journal of Clinical Oncology | 2005 | 255 |
| 12 | Diagnostic Performance of Quantitative κ and λ Free Light Chain Assays in Clinical Practice | Clinical Chemistry | 2005 | 244 |
| 13 | Treatment of multiple myeloma | Nature Reviews Clinical Oncology | 2011 | 239 |
| 14 | Prospective Evaluation of Clonal Evolution During Long-Term Follow-Up of Patients With Untreated Early-Stage Chronic Lymphocytic Leukemia | Journal of Clinical Oncology | 2006 | 223 |
| 15 | Mayo Clinic Consensus Statement for the Use of Bisphosphonates in Multiple Myeloma | Mayo Clinic Proceedings | 2006 | 221 |
| 16 | Hematological manifestations of copper deficiency: a retrospective review | European Journal of Haematology | 2008 | 219 |
| 17 | Non-Hodgkin Lymphoma: Diagnosis and Treatment | Mayo Clinic Proceedings | 2005 | 214 |
| 18 | Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma | Blood | 2005 | 213 |
| 19 | Multiple Myeloma: Diagnosis and Treatment | Mayo Clinic Proceedings | 2005 | 210 |
| 20 | Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis | Cancer Cell | 2005 | 202 |
| 21 | The Myelodysplastic Syndromes: Diagnosis and Treatment | Mayo Clinic Proceedings | 2006 | 190 |
| 22 | Thrombosis in Myeloproliferative Disorders: Prevalence, Prognostic Factors, and the Role of Leukocytes and JAK2V617F | Seminars in Thrombosis and Hemostasis | 2007 | 189 |
| 23 | Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia | Blood | 2013 | 184 |
| 24 | Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM) | Leukemia | 2010 | 182 |
| 25 | Monoclonal Gammopathy of Undetermined Significance, Waldenström Macroglobulinemia, AL Amyloidosis, and Related Plasma Cell Disorders: Diagnosis and Treatment | Mayo Clinic Proceedings | 2006 | 181 |
| 26 | Elimination of the Need for Urine Studies in the Screening Algorithm for Monoclonal Gammopathies by Using Serum Immunofixation and Free Light Chain Assays | Mayo Clinic Proceedings | 2006 | 179 |
| 27 | Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress | Blood | 2007 | 176 |
| 28 | Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification | Blood | 2015 | 176 |
| 29 | Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells | Nanomedicine: Nanotechnology, Biology, and Medicine | 2007 | 166 |
| 30 | Hypertension in pregnancy: an emerging risk factor for cardiovascular disease | Nature Clinical Practice Nephrology | 2007 | 161 |
| 31 | Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome) | Blood | 2012 | 159 |
| 32 | Low-Molecular-Weight Heparin in Patients With Advanced Cancer: A Phase 3 Clinical Trial | Mayo Clinic Proceedings | 2006 | 156 |
| 33 | Treatment of Newly Diagnosed Multiple Myeloma Based on Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART): Consensus Statement | Mayo Clinic Proceedings | 2007 | 155 |
| 34 | Mutations in the chromatin-associated protein ATRX | Human Mutation | 2008 | 155 |
| 35 | Immunoglobulin free light chains and solitary plasmacytoma of bone | Blood | 2006 | 152 |
| 36 | CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential | British Journal of Haematology | 2008 | 152 |
| 37 | Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia | Cancer | 2007 | 145 |
| 38 | Treatment of Newly Diagnosed Multiple Myeloma Based on Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART): Consensus Statement | Mayo Clinic Proceedings | 2007 | 143 |
| 39 | Early Lymphocyte Recovery Predicts Superior Survival after Autologous Stem Cell Transplantation in Non-Hodgkin Lymphoma: A Prospective Study | Biology of Blood and Marrow Transplantation | 2008 | 141 |
| 40 | Multiple myeloma: 2011 update on diagnosis, risk‐stratification, and management | American Journal of Hematology | 2011 | 137 |
| 41 | Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone | Blood | 2009 | 130 |
| 42 | Recurrent membranoproliferative glomerulonephritis after kidney transplantation | Kidney International | 2010 | 128 |
| 43 | Imatinib targets other than bcr/abl and their clinical relevance in myeloid disorders | Blood | 2004 | 125 |
| 44 | The influence of personal and environmental factors on professionalism in medical education | BMC Medical Education | 2007 | 121 |
| 45 | Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients | Blood | 2010 | 119 |
| 46 | Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine | Blood | 2005 | 118 |
| 47 | Autologous Stem Cell Transplant after Heart Transplant for Light Chain (AL) Amyloid Cardiomyopathy | Journal of Heart and Lung Transplantation | 2008 | 117 |
| 48 | Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome | European Journal of Haematology | 2008 | 116 |
| 49 | 6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis | British Journal of Haematology | 2007 | 109 |
| 50 | Oncolytic measles virus targets high CD46 expression on multiple myeloma cells | Experimental Hematology | 2006 | 107 |
